{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:07:22Z","timestamp":1780337242731,"version":"3.54.1"},"posted":{"date-parts":[[2026,1,13]]},"group-title":"In Review","reference-count":82,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,6]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Accelerated immune cell aging is well-recognized feature of Down Syndrome (DS), a condition caused by trisomy of human chromosome 21 (\n                  <italic>Hsa21<\/italic>\n                  ). DS predisposes individuals to recurrent infections, autoimmunity, low bone mass and leukemia. To investigate potential connections between immune cell dysfunction or disruption in DS, serum transcriptomic and proteomic datasets from DS and euploid individuals were examined. High DS superoxide dismutase 1 (\n                  <italic>SOD1<\/italic>\n                  ) mRNA expression was consistently found and was strongly associated with an increased odds of inflammatory co-occurring conditions such as pharyngitis.\n                  <italic>SOD1<\/italic>\n                  mRNA overexpression was also associated with decreased M2-polarized macrophages, increased resting-memory CD4\u2009+\u2009T cells, elevated serum interleukin-16 levels and interferon-\u03b3 protein levels, indicative of pathological pro-inflammatory immune dysregulation.\n                  <italic>SOD1<\/italic>\n                  mRNA was co-overexpressed with glutathione and thioredoxin-dependent pathways, both are integral to the antioxidative responses and the generation of hydrogen sulfide (H\n                  <sub>2<\/sub>\n                  S). Although H\n                  <sub>2<\/sub>\n                  S overproduction in DS has been attributed to the overexpression of cystathionine-\u03b2-synthase (\n                  <italic>CBS<\/italic>\n                  ), no consistent\n                  <italic>CBS<\/italic>\n                  mRNA elevation was observed in this study. Conversely, the increased expression of a thioredoxin-dependent cysteine catabolism pathway suggests noncanonical H\n                  <sub>2<\/sub>\n                  S overproduction in DS distinct from\n                  <italic>CBS<\/italic>\n                  . Our findings highlight the unexpected relationship between oxidative stress homeostasis and H\n                  <sub>2<\/sub>\n                  S overproduction in DS, extending beyond\n                  <italic>Hsa21<\/italic>\n                  trisomy.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8535243\/v1","type":"posted-content","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T10:24:57Z","timestamp":1768299897000},"source":"Crossref","is-referenced-by-count":0,"title":["SOD1 at the Crossroads: Co-Overexpression of Canonical Antioxidant Response and Noncanonical Hydrogen Sulfide Generation Pathways in Down Syndrome, With Immune Cell Implications"],"prefix":"10.21203","author":[{"given":"Karthik","family":"Mouli","sequence":"first","affiliation":[{"name":"Texas A&M Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton V.","family":"Liopo","sequence":"additional","affiliation":[{"name":"Texas A&M Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Wang","sequence":"additional","affiliation":[{"name":"Texas A&M Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Suva","sequence":"additional","affiliation":[{"name":"Texas A&M University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Olson","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine South Bend"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Derry","sequence":"additional","affiliation":[{"name":"Texas A&M Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Kent","sequence":"additional","affiliation":[{"name":"Texas A&M Health Science Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","article-title":"Down syndrome","volume":"6","author":"Antonarakis SE","year":"2020","unstructured":"Antonarakis, S. E. et al. Down syndrome. Nat. Rev. Dis. Primers. 6, 9. 10.1038\/s41572-019-0143-7 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1038\/s41467-024-49781-1","article-title":"Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome","volume":"15","author":"Donovan MG","year":"2024","unstructured":"Donovan, M. G. et al. Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome. Nat. Commun. 15, 5473. 10.1038\/s41467-024-49781-1 (2024).","journal-title":"Nat. Commun."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"eadg6218","DOI":"10.1126\/sciadv.adg6218","article-title":"Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition","volume":"9","author":"Galbraith MD","unstructured":"Galbraith, M. D. et al. Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. Science Advances 9, eadg6218, 10.1126\/sciadv.adg6218","journal-title":"Science Advances"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/children11020246","article-title":"Recurrent Respiratory Infections in Children with Down Syndrome: A Review","volume":"11","author":"Ghezzi M","year":"2024","unstructured":"Ghezzi, M. et al. Recurrent Respiratory Infections in Children with Down Syndrome: A Review. Child. (Basel). 11 10.3390\/children11020246 (2024).","journal-title":"Child. (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/erm.2021.6","article-title":"Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view","volume":"23","author":"Hasaart KAL","year":"2021","unstructured":"Hasaart, K. A. L., Bertrums, E. J. M., Manders, F., Goemans, B. F. & van Boxtel, R. Increased risk of leukaemia in children with Down syndrome: a somatic evolutionary view. Expert Rev. Mol. Med. 23, e5. 10.1017\/erm.2021.6 (2021).","journal-title":"Expert Rev. Mol. Med."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"669893","DOI":"10.3389\/fimmu.2021.669893","article-title":"Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients","volume":"12","author":"Marcovecchio GE","year":"2021","unstructured":"Marcovecchio, G. E. et al. Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients. Front. Immunol. 12, 669893. 10.3389\/fimmu.2021.669893 (2021).","journal-title":"Front. Immunol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome","volume":"164","author":"Ram G","year":"2011","unstructured":"Ram, G. & Chinen, J. Infections and immunodeficiency in Down syndrome. Clin. Exp. Immunol. 164, 9\u201316. 10.1111\/j.1365-2249.2011.04335.x (2011).","journal-title":"Clin. Exp. Immunol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41586-024-07946-4","article-title":"Single-cell multi-omics map of human fetal blood in Down syndrome","volume":"634","author":"Marderstein AR","year":"2024","unstructured":"Marderstein, A. R. et al. Single-cell multi-omics map of human fetal blood in Down syndrome. Nature 634, 104\u2013112. 10.1038\/s41586-024-07946-4 (2024).","journal-title":"Nature"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fnins.2020.00670","article-title":"Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions","volume":"14","author":"Dierssen M","year":"2020","unstructured":"Dierssen, M., Fructuoso, M., Mart\u00ednez de Lagr\u00e1n, M., Perluigi, M. & Barone, E. Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions. Front. Neurosci. 14, 670. 10.3389\/fnins.2020.00670 (2020).","journal-title":"Front. Neurosci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/s0140-6736(03)12987-x","article-title":"Down's syndrome","volume":"361","author":"Roizen NJ","year":"2003","unstructured":"Roizen, N. J. & Patterson, D. Down's syndrome. Lancet 361, 1281\u20131289. 10.1016\/s0140-6736(03)12987-x (2003).","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"7147","DOI":"10.1073\/pnas.0709451105","article-title":"Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling","volume":"105","author":"Juarez JC","year":"2008","unstructured":"Juarez, J. C. et al. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. U S A. 105, 7147\u20137152. 10.1073\/pnas.0709451105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2310\/6650.2001.34089","article-title":"Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome","volume":"49","author":"Gulesserian T","year":"2001","unstructured":"Gulesserian, T., Seidl, R., Hardmeier, R., Cairns, N. & Lubec, G. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome. J. Investig Med. 49, 41\u201346. 10.2310\/6650.2001.34089 (2001).","journal-title":"J. Investig Med."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s0891-5849(01)00609-8","article-title":"Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients","volume":"31","author":"Muchov\u00e1 J","year":"2001","unstructured":"Muchov\u00e1, J. et al. Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients. Free Radic Biol. Med. 31, 499\u2013508. 10.1016\/s0891-5849(01)00609-8 (2001).","journal-title":"Free Radic Biol. Med."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/724904","author":"Perluigi M","year":"2012","unstructured":"Perluigi, M. & Butterfield, D. A. Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia. Curr Gerontol Geriatr Res 724904, (2012). 10.1155\/2012\/724904 (2012)."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/j.1471-4159.2009.06294.x","article-title":"Increased lipid peroxidation in Down's syndrome mouse models","volume":"110","author":"Ishihara K","year":"2009","unstructured":"Ishihara, K. et al. Increased lipid peroxidation in Down's syndrome mouse models. J. Neurochem. 110, 1965\u20131976. 10.1111\/j.1471-4159.2009.06294.x (2009).","journal-title":"J. Neurochem"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tibs.2015.05.001","article-title":"Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling","volume":"40","author":"Perkins A","year":"2015","unstructured":"Perkins, A., Nelson, K. J., Parsonage, D., Poole, L. B. & Karplus, P. A. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem. Sci. 40, 435\u2013445. 10.1016\/j.tibs.2015.05.001 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1083\/jcb.134.4.849","article-title":"Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence","volume":"134","author":"Purdue PE","year":"1996","unstructured":"Purdue, P. E. & Lazarow, P. B. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence. J. Cell. Biol. 134, 849\u2013862. 10.1083\/jcb.134.4.849 (1996).","journal-title":"J. Cell. Biol."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3390\/antiox13111361","article-title":"SOD1 Is an Integral Yet Insufficient Oxidizer of Hydrogen Sulfide in Trisomy 21 B Lymphocytes and Can Be Augmented by a Pleiotropic Carbon Nanozyme","volume":"13","author":"Mouli K","year":"2024","unstructured":"Mouli, K. et al. SOD1 Is an Integral Yet Insufficient Oxidizer of Hydrogen Sulfide in Trisomy 21 B Lymphocytes and Can Be Augmented by a Pleiotropic Carbon Nanozyme. Antioxidants 13, 1361 (2024).","journal-title":"Antioxidants"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1111\/febs.15214","article-title":"The re-emerging pathophysiological role of the cystathionine-\u03b2-synthase - hydrogen sulfide system in Down syndrome","volume":"287","author":"Szabo C","year":"2020","unstructured":"Szabo, C. The re-emerging pathophysiological role of the cystathionine-\u03b2-synthase - hydrogen sulfide system in Down syndrome. Febs j. 287, 3150\u20133160. 10.1111\/febs.15214 (2020).","journal-title":"Febs j."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e00584","DOI":"10.1016\/j.neurot.2025.e00584","article-title":"Role of cystathionine-\u03b2-synthase and hydrogen sulfide in down syndrome","author":"Szabo C","year":"2025","unstructured":"Szabo, C. Role of cystathionine-\u03b2-synthase and hydrogen sulfide in down syndrome. Neurotherapeutics e00584. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00584 (2025).","journal-title":"Neurotherapeutics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajmg.a.10847","article-title":"Chadefaux-Vekemans, B. Endogenous hydrogen sulfide overproduction in Down syndrome","volume":"116a","author":"Kamoun P","year":"2003","unstructured":"Kamoun, P., Belardinelli, M. C., Chabli, A. & Lallouchi, K. Chadefaux-Vekemans, B. Endogenous hydrogen sulfide overproduction in Down syndrome. Am. J. Med. Genet. A. 116a, 310\u2013311. 10.1002\/ajmg.a.10847 (2003).","journal-title":"Am. J. Med. Genet. A"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1007\/s11357-024-01146-8","article-title":"Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine \u03b2-synthase, H(2)S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy","volume":"46","author":"Panagaki T","year":"2024","unstructured":"Panagaki, T. et al. Neurobehavioral dysfunction in a mouse model of Down syndrome: upregulation of cystathionine \u03b2-synthase, H(2)S overproduction, altered protein persulfidation, synaptic dysfunction, endoplasmic reticulum stress, and autophagy. Geroscience 46, 4275\u20134314. 10.1007\/s11357-024-01146-8 (2024).","journal-title":"Geroscience"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911895116","author":"Panagaki T","year":"2019","unstructured":"Panagaki, T., Randi, E. B., Augsburger, F. & Szabo, C. Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome. Proceedings of the National Academy of Sciences 116, 18769\u201318771, doi: (2019). 10.1073\/pnas.1911895116"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/biom10040653","author":"Panagaki T","year":"2020","unstructured":"Panagaki, T., Randi, E. B. & Szabo, C. Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts. Biomolecules 10, (2020). 10.3390\/biom10040653"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.freeradbiomed.2016.02.028","article-title":"The role of glutathione reductase and related enzymes on cellular redox homoeostasis network","volume":"95","author":"Couto N","year":"2016","unstructured":"Couto, N., Wood, J. & Barber, J. The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radic Biol. Med. 95, 27\u201342. 10.1016\/j.freeradbiomed.2016.02.028 (2016).","journal-title":"Free Radic Biol. Med."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/hsz-2020-0249","article-title":"3-Mercaptopyruvate sulfurtransferase: an enzyme at the crossroads of sulfane sulfur trafficking","volume":"402","author":"Pedre B","year":"2021","unstructured":"Pedre, B. & Dick, T. P. 3-Mercaptopyruvate sulfurtransferase: an enzyme at the crossroads of sulfane sulfur trafficking. 402, 223\u2013237, doi: (2021). 10.1515\/hsz-2020-0249"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e2205044120","DOI":"10.1073\/pnas.2205044120","article-title":"SOD1 is an essential H(2)S detoxifying enzyme","volume":"120","author":"Switzer CH","year":"2023","unstructured":"Switzer, C. H., Kasamatsu, S., Ihara, H. & Eaton, P. SOD1 is an essential H(2)S detoxifying enzyme. Proc. Natl. Acad. Sci. U S A. 120, e2205044120. 10.1073\/pnas.2205044120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li B","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323. 10.1186\/1471-2105-12-323 (2011).","journal-title":"BMC Bioinform."},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.71738\/P0A9-2V09","author":"Espinosa J","year":"2022","unstructured":"Espinosa, J. The Human Trisome Project. (2022). 10.71738\/P0A9-2V09"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham H","year":"2019","unstructured":"Wickham, H. et al. Welcome to the Tidyverse. J. Open. Source Softw. 4, 1686. 10.21105\/joss.01686 (2019).","journal-title":"J. Open. Source Softw."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson MD","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. 10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini Y","year":"2001","unstructured":"Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. & Golani, I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279\u2013284. 10.1016\/s0166-4328(01)00297-2 (2001).","journal-title":"Behav. Brain Res."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fgene.2019.00858","article-title":"An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks","volume":"10","author":"Ulgen E","year":"2019","unstructured":"Ulgen, E., Ozisik, O., Sezerman, O. U. & pathfindR An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks. Front. Genet. 10, 858. 10.3389\/fgene.2019.00858 (2019).","journal-title":"Front. Genet."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat A","year":"2017","unstructured":"Fabregat, A. et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinform. 18, 142. 10.1186\/s12859-017-1559-2 (2017).","journal-title":"BMC Bioinform."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman AM","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782. 10.1038\/s41587-019-0114-2 (2019).","journal-title":"Nat. Biotechnol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu Z","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849. 10.1093\/bioinformatics\/btw313 (2016).","journal-title":"Bioinformatics"},{"key":"ref37","author":"Pedersen TL","year":"2025","unstructured":"Pedersen, T. L. ggforce: Accelerating 'ggplot2'. (2025)."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","article-title":"Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets","volume":"24","author":"Izzo A","year":"2018","unstructured":"Izzo, A. et al. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets. Mol. Med. 24, 2. 10.1186\/s10020-018-0004-y (2018).","journal-title":"Mol. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2164-12-229","article-title":"Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes","volume":"12","author":"Vilardell M","year":"2011","unstructured":"Vilardell, M. et al. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genom. 12, 229. 10.1186\/1471-2164-12-229 (2011).","journal-title":"BMC Genom."},{"key":"ref40","volume-title":"A flexible Python implementation of the Mapper algorithm v. v2.0.1","author":"Kepler Mapper","year":"2021","unstructured":"Kepler Mapper. A flexible Python implementation of the Mapper algorithm v. v2.0.1 (Zenodo, 2021)."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.21105\/joss.01315","article-title":"Kepler Mapper: A flexible Python implementation of the Mapper algorithm","volume":"4","author":"Veen HJ","year":"2019","unstructured":"van Veen, H. J., Saul, N., Eargle, D. & Mangham, S. W. Kepler Mapper: A flexible Python implementation of the Mapper algorithm. J. Open. Source Softw. 4, 1315. 10.21105\/joss.01315 (2019).","journal-title":"J. Open. Source Softw."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1145\/2133360.2133363","article-title":"Isolation-Based Anomaly Detection","volume":"6","author":"Liu FT","year":"2012","unstructured":"Liu, F. T., Ting, K. M. & Zhou, Z. H. Isolation-Based Anomaly Detection. ACM Trans. Knowl. Discov Data. 6, Article 3, 10.1145\/2133360.2133363 (2012).","journal-title":"ACM Trans. Knowl. Discov Data"},{"key":"ref43","author":"Singh G","year":"2007","unstructured":"Singh, G., Memoli, F. & Carlsson, G. in Eurographics Symposium on Point-Based Graphics (eds M. Botsch, R. Pajarola, B. Chen, & M. Zwicker)The Eurographics Association, (2007)."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","article-title":"Ward\u2019s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward\u2019s Criterion?","volume":"31","author":"Murtagh F","year":"2014","unstructured":"Murtagh, F. & Legendre, P. Ward\u2019s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward\u2019s Criterion? J. Classif. 31, 274\u2013295. 10.1007\/s00357-014-9161-z (2014).","journal-title":"J. Classif."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816460","author":"R\u0151szer T","year":"2015","unstructured":"R\u0151szer, T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators of Inflammation 816460, (2015). https:\/\/doi.org\/10.1155\/2015\/816460 (2015)."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.13253","article-title":"The role of hydrogen sulphide signalling in macrophage activation","volume":"162","author":"Sun F","year":"2021","unstructured":"Sun, F. et al. The role of hydrogen sulphide signalling in macrophage activation. Immunology 162, 3\u201310. https:\/\/doi.org\/10.1111\/imm.13253 (2021).","journal-title":"Immunology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e2202380","DOI":"10.1002\/adhm.202202380","article-title":"Nitric Oxide Scavenging and Hydrogen Sulfide Production Synergistically Treat Rheumatoid Arthritis","volume":"12","author":"Geng W","year":"2023","unstructured":"Geng, W. et al. Nitric Oxide Scavenging and Hydrogen Sulfide Production Synergistically Treat Rheumatoid Arthritis. Adv. Healthc. Mater. 12, e2202380. 10.1002\/adhm.202202380 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1089\/ars.2012.5041","article-title":"Polysulfides link H2S to protein thiol oxidation","volume":"19","author":"Greiner R","year":"2013","unstructured":"Greiner, R. et al. Polysulfides link H2S to protein thiol oxidation. Antioxid. Redox Signal. 19, 1749\u20131765. 10.1089\/ars.2012.5041 (2013).","journal-title":"Antioxid. Redox Signal."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/cbic.202000661","article-title":"Hydrogen Sulfide Oxidation by Sulfide Quinone Oxidoreductase","volume":"22","author":"Landry AP","year":"2021","unstructured":"Landry, A. P., Ballou, D. P. & Banerjee, R. Hydrogen Sulfide Oxidation by Sulfide Quinone Oxidoreductase. Chembiochem 22, 949\u2013960. 10.1002\/cbic.202000661 (2021).","journal-title":"Chembiochem"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.smim.2009.02.006","article-title":"CD4 memory T cells: what are they and what can they do?","volume":"21","author":"MacLeod MK","year":"2009","unstructured":"MacLeod, M. K., Clambey, E. T., Kappler, J. W. & Marrack, P. CD4 memory T cells: what are they and what can they do? Semin Immunol. 21, 53\u201361. 10.1016\/j.smim.2009.02.006 (2009).","journal-title":"Semin Immunol."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030531","author":"Raphael I","year":"2020","unstructured":"Raphael, I., Joern, R. R. & Forsthuber, T. G. Memory CD4(+) T Cells in Immunity and Autoimmune Diseases. Cells 9, (2020). 10.3390\/cells9030531"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fimmu.2025.1524026","article-title":"Role of interleukin-16 in human diseases: a novel potential therapeutic target","author":"Niewold TB","year":"2025","unstructured":"Niewold, T. B., Lehman, J. S., Gunnarsson, I., Meves, A. & Oke, V. Role of interleukin-16 in human diseases: a novel potential therapeutic target. Front. Immunol. 16\u20132025. 10.3389\/fimmu.2025.1524026 (2025).","journal-title":"Front. Immunol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv LB","year":"2018","unstructured":"Ivashkiv, L. B. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat. Rev. Immunol. 18, 545\u2013558. 10.1038\/s41577-018-0029-z (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41586-023-05736-y","article-title":"Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c(+) B cells","volume":"615","author":"Malle L","year":"2023","unstructured":"Malle, L. et al. Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c(+) B cells. Nature 615, 305\u2013314. 10.1038\/s41586-023-05736-y (2023).","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk D","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638\u2013d646. 10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The Reactome Pathway Knowledgebase 2024","volume":"52","author":"Milacic M","year":"2024","unstructured":"Milacic, M. et al. The Reactome Pathway Knowledgebase 2024. Nucleic Acids Res. 52, D672\u2013d678. 10.1093\/nar\/gkad1025 (2024).","journal-title":"Nucleic Acids Res."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0304-3940(97)00748-9","article-title":"Evidence against increased oxidative DNA-damage in Down syndrome","volume":"235","author":"Seidl R","year":"1997","unstructured":"Seidl, R. et al. Evidence against increased oxidative DNA-damage in Down syndrome. Neurosci. Lett. 235, 137\u2013140. 10.1016\/s0304-3940(97)00748-9 (1997).","journal-title":"Neurosci. Lett."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051012","article-title":"Peroxiredoxin 2: An Important Element of the Antioxidant Defense of the Erythrocyte","volume":"12","author":"Sadowska-Bartosz I","year":"2023","unstructured":"Sadowska-Bartosz, I. & Bartosz, G. Peroxiredoxin 2: An Important Element of the Antioxidant Defense of the Erythrocyte. Antioxid. (Basel). 12 10.3390\/antiox12051012 (2023).","journal-title":"Antioxid. (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2022.04.015","article-title":"Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21","volume":"186","author":"Prutton KM","year":"2022","unstructured":"Prutton, K. M. et al. Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21. Free Radic. Biol. Med. 186, 32\u201342. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.04.015 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.mbplus.2021.100057","article-title":"The Nrf2 transcription factor: A multifaceted regulator of the extracellular matrix","volume":"10","author":"Hiebert P","year":"2021","unstructured":"Hiebert, P. The Nrf2 transcription factor: A multifaceted regulator of the extracellular matrix. Matrix Biology Plus. 10, 100057. https:\/\/doi.org\/10.1016\/j.mbplus.2021.100057 (2021).","journal-title":"Matrix Biology Plus"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41419-019-1752-5","article-title":"mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy","volume":"10","author":"Bordi M","year":"2019","unstructured":"Bordi, M. et al. mTOR hyperactivation in Down Syndrome underlies deficits in autophagy induction, autophagosome formation, and mitophagy. Cell. Death Dis. 10, 563. 10.1038\/s41419-019-1752-5 (2019).","journal-title":"Cell. Death Dis."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2211241","DOI":"10.1002\/adma.202211241","article-title":"Oxidation of Hydrogen Sulfide to Polysulfide and Thiosulfate by a Carbon Nanozyme: Therapeutic Implications with an Emphasis on Down Syndrome","volume":"36","author":"Derry PJ","year":"2024","unstructured":"Derry, P. J. et al. Oxidation of Hydrogen Sulfide to Polysulfide and Thiosulfate by a Carbon Nanozyme: Therapeutic Implications with an Emphasis on Down Syndrome. Adv. Mater. 36, 2211241. https:\/\/doi.org\/10.1002\/adma.202211241 (2024).","journal-title":"Adv. Mater."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"40227","DOI":"10.1038\/srep40227","article-title":"Discovery and Mechanistic Characterization of Selective Inhibitors of H(2)S-producing Enzyme: 3-Mercaptopyruvate Sulfurtransferase (3MST) Targeting Active-site Cysteine Persulfide","volume":"7","author":"Hanaoka K","year":"2017","unstructured":"Hanaoka, K. et al. Discovery and Mechanistic Characterization of Selective Inhibitors of H(2)S-producing Enzyme: 3-Mercaptopyruvate Sulfurtransferase (3MST) Targeting Active-site Cysteine Persulfide. Sci. Rep. 7, 40227. 10.1038\/srep40227 (2017).","journal-title":"Sci. Rep."},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25173984","article-title":"Cysteine Aminotransferase (CAT): A Pivotal Sponsor in Metabolic Remodeling and an Ally of 3-Mercaptopyruvate Sulfurtransferase (MST) in Cancer","volume":"25","author":"Hip\u00f3lito A","year":"2020","unstructured":"Hip\u00f3lito, A., Nunes, S. C., Vicente, J. B. & Serpa, J. Cysteine Aminotransferase (CAT): A Pivotal Sponsor in Metabolic Remodeling and an Ally of 3-Mercaptopyruvate Sulfurtransferase (MST) in Cancer. Molecules 25 10.3390\/molecules25173984 (2020).","journal-title":"Molecules"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.lfs.2013.08.017","article-title":"Systemic oxidative stress in children and teenagers with Down syndrome","volume":"93","author":"Garlet TR","year":"2013","unstructured":"Garlet, T. R. et al. Systemic oxidative stress in children and teenagers with Down syndrome. Life Sci. 93, 558\u2013563. 10.1016\/j.lfs.2013.08.017 (2013).","journal-title":"Life Sci."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e0176307","DOI":"10.1371\/journal.pone.0176307","article-title":"The burden of trisomy 21 disrupts the proteostasis network in Down syndrome","volume":"12","author":"Aivazidis S","year":"2017","unstructured":"Aivazidis, S. et al. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PLoS One. 12, e0176307. 10.1371\/journal.pone.0176307 (2017).","journal-title":"PLoS One"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1515\/cclm.1988.26.5.255","article-title":"Glutathione Peroxidase Activity, Lipid Peroxides and Selenium Status in Blood in Patients with Down\u2019s Syndrome","volume":"26","author":"Gromadzi\u0144ska J","year":"1988","unstructured":"Gromadzi\u0144ska, J., Wasowicz, W., Sktodowska, M. & Str\u00f3\u017cy\u0144ski, H. Glutathione Peroxidase Activity, Lipid Peroxides and Selenium Status in Blood in Patients with Down\u2019s Syndrome. Clin. Chem. Lab. Med. (CCLM). 26, 255\u2013258. 10.1515\/cclm.1988.26.5.255 (1988).","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00042752-200607000-00013","article-title":"Regular physical activity increases glutathione peroxidase activity in adolescents with Down syndrome","volume":"16","author":"Francisco Javier O","year":"2006","unstructured":"Francisco Javier, O., Manuel, R. & Manuel, R. R. Regular physical activity increases glutathione peroxidase activity in adolescents with Down syndrome. Clin. J. Sport Med. 16, 355\u2013356. 10.1097\/00042752-200607000-00013 (2006).","journal-title":"Clin. J. Sport Med."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00018-003-3048-1","article-title":"Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains","volume":"60","author":"S\u00e1nchez-Font MF","year":"2003","unstructured":"S\u00e1nchez-Font, M. F. et al. Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains. Cell. Mol. Life Sci. 60, 1513\u20131523. 10.1007\/s00018-003-3048-1 (2003).","journal-title":"Cell. Mol. Life Sci."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","article-title":"The thioredoxin antioxidant system","volume":"66","author":"Lu J","year":"2014","unstructured":"Lu, J. & Holmgren, A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 66, 75\u201387. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.07.036 (2014).","journal-title":"Free Radic. Biol. Med."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1016\/j.freeradbiomed.2018.10.354","article-title":"324 - Investigation of cytoplasmic and mitochondrial redox status in Down syndrome: impact of the thioredoxin and glutathione systems","volume":"128","author":"Roede J","year":"2018","unstructured":"Roede, J. 324 - Investigation of cytoplasmic and mitochondrial redox status in Down syndrome: impact of the thioredoxin and glutathione systems. Free Radic. Biol. Med. 128, S134. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.354 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione: overview of its protective roles, measurement, and biosynthesis","volume":"30","author":"Forman HJ","year":"2009","unstructured":"Forman, H. J., Zhang, H. & Rinna, A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol. Aspects Med. 30, 1\u201312. 10.1016\/j.mam.2008.08.006 (2009).","journal-title":"Mol. Aspects Med."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mam.2008.08.009","article-title":"Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase","volume":"30","author":"Franklin CC","year":"2009","unstructured":"Franklin, C. C. et al. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol. Aspects Med. 30, 86\u201398. 10.1016\/j.mam.2008.08.009 (2009).","journal-title":"Mol. Aspects Med."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/321262","article-title":"Homocysteine metabolism in children with Down syndrome: in vitro modulation","volume":"69","author":"Pogribna M","year":"2001","unstructured":"Pogribna, M. et al. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am. J. Hum. Genet. 69, 88\u201395. 10.1086\/321262 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2174\/092986706776360914","article-title":"The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase","volume":"13","author":"Nagahara N","year":"2006","unstructured":"Nagahara, N. & Sawada, N. The mercaptopyruvate pathway in cysteine catabolism: a physiologic role and related disease of the multifunctional 3-mercaptopyruvate sulfurtransferase. Curr. Med. Chem. 13, 1219\u20131230. 10.2174\/092986706776360914 (2006).","journal-title":"Curr. Med. Chem."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1089\/ars.2020.8132","article-title":"Are Reactive Sulfur Species the New Reactive Oxygen Species?","volume":"33","author":"Olson KR","year":"2020","unstructured":"Olson, K. R. Are Reactive Sulfur Species the New Reactive Oxygen Species? Antioxid. Redox. Signal. 33, 1125\u20131142. 10.1089\/ars.2020.8132 (2020).","journal-title":"Antioxid. Redox. Signal."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1042\/bj20110841","article-title":"Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide","volume":"439","author":"Mikami Y","year":"2011","unstructured":"Mikami, Y. et al. Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem. J. 439, 479\u2013485. 10.1042\/bj20110841 (2011).","journal-title":"Biochem. J."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","article-title":"Adaptive downregulation of mitochondrial function in down syndrome","volume":"17","author":"Helguera P","year":"2013","unstructured":"Helguera, P. et al. Adaptive downregulation of mitochondrial function in down syndrome. Cell. Metab. 17, 132\u2013140. 10.1016\/j.cmet.2012.12.005 (2013).","journal-title":"Cell. Metab."},{"key":"ref79","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/antiox12020344","article-title":"Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage","volume":"12","author":"Marini E","year":"2023","unstructured":"Marini, E. et al. Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants 12, 344 (2023).","journal-title":"Antioxidants"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2017.12.010","article-title":"H2S and polysulfide metabolism: Conventional and unconventional pathways","volume":"149","author":"Olson KR","year":"2018","unstructured":"Olson, K. R. H2S and polysulfide metabolism: Conventional and unconventional pathways. Biochem. Pharmacol. 149, 77\u201390. https:\/\/doi.org\/10.1016\/j.bcp.2017.12.010 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/ars.2023.0352","article-title":"Emerging Chemical Biology of Protein Persulfidation","volume":"39","author":"Vignane T","year":"2023","unstructured":"Vignane, T. & Filipovic, M. R. Emerging Chemical Biology of Protein Persulfidation. Antioxid. Redox Signal. 39, 19\u201339. 10.1089\/ars.2023.0352 (2023).","journal-title":"Antioxid. Redox Signal."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"eaax8358","DOI":"10.1126\/sciadv.aax8358","article-title":"Control of protein function through oxidation and reduction of persulfidated states","volume":"6","author":"D\u00f3ka \u00c9","year":"2020","unstructured":"D\u00f3ka, \u00c9. et al. Control of protein function through oxidation and reduction of persulfidated states. Sci. Adv. 6, eaax8358. 10.1126\/sciadv.aax8358 (2020).","journal-title":"Sci. Adv."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8535243\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8535243\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:27:51Z","timestamp":1780334871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8535243\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":82,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8535243\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-026-45627-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,1,13]]},"subtype":"preprint"}}